Tag: drug
Ipsen’s $247M Epizyme acquisition brings approved cancer drug & more in...
Ipsen has been reshaping its drug lineup by striking deals and its latest one is a $247 million agreement to acquire Epizyme, a cancer...
GW plots path to new drug approvals as Epidiolex tops sales...
GW Pharmaceuticals is looking to blaze new trails in cannabinoid prescription meds, this time in multiple sclerosis. The company has launched a phase 3 trial of...
Merck looks ahead to a COVID drug and vaccine—and a Gardasil...
Merck & Co. is having a decent year, financially speaking. If not for the COVID-19 pandemic, it would be a great one.
The pharma giant...
Merck, plagued by limited supply of bladder cancer drug, will build...
During its years as sole producer of a difficult-to-make cancer med in high demand, Merck & Co.'s limited capacity has hamstrung its efforts to...
Teva back on the hook for $235M to GSK for heart...
After a jury in 2017 ordered Teva to pay $235 million for patent infringement of a GlaxoSmithKline heart drug, the generics giant convinced a district...
Monte Rosa raises $96M Series B for drug development platform technology
A startup developing a platform technology for drugs that degrade proteins that cause disease has raised a financing round of nearly $100 million.
Boston-based Monte...
J&J’s next-gen Darzalex sparks drug delivery royalties battle
Johnson & Johnson scaled back its Darzalex royalty payments to Genmab in the second quarter, just as its new subcutaneous formulation was hitting the...
Bristol Myers Squibb’s targeted AML drug Idhifa fails to extend patients’...
Back in 2017, the FDA cleared Celgene's acute myeloid leukemia therapy Idhifa based on complete remission data. But fast forward to today, and the drug has...
Metformin recalls continue as Bayshore pulls diabetes drug on carcinogen scare
After finding high levels of a probable carcinogen in samples of the common diabetes med metformin, the FDA has scrambled to get affected lots...
House Dems launch probe into Kodak’s unexpected $765M drug manufacturing loan...
The Trump administration’s surprising $765 million deal that would enable former photography giant Kodak to start making drug ingredients has yet to be finalized,...
